SUO 2020: Oncologic Outcomes of Mohs Surgery for Localized Penile Carcinoma: A 10-Year Retrospective Study

(UroToday.com) Penile cancer is a rare malignancy with an annual incidence of 0.1-0.7 in 100,000 men, which accounts for fewer than 1% of male cancers in the United States. Treatment is often associated with considerable mutilation and changes to quality of life. Organ sparing surgery for the management of localized penile cancer has the potential […]

SUO 2020: Neoadjuvant Checkpoints: Exploring the Emerging Utility of Immune Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer

(UroToday.com) At the 2020 Society of Urologic Oncology (SUO) virtual annual meeting, Dr. Neal Shore chaired a session examining the use of newer and emerging agents in bladder cancer, which highlighted a presentation by medical oncologist Dr. Arjun Balar discussing the emerging utility of immune checkpoint inhibitors in muscle-invasive bladder cancer (MIBC).

X